These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18539457)

  • 21. Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough.
    Soelaiman S; Wei BQ; Bergson P; Lee YS; Shen Y; Mrksich M; Shoichet BK; Tang WJ
    J Biol Chem; 2003 Jul; 278(28):25990-7. PubMed ID: 12676933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli.
    Mock M; Labruyère E; Glaser P; Danchin A; Ullmann A
    Gene; 1988 Apr; 64(2):277-84. PubMed ID: 2841199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quickening the pace of anthrax research: three advances point towards possible therapies.
    Chaudry GJ; Moayeri M; Liu S; Leppla SH
    Trends Microbiol; 2002 Feb; 10(2):58-62. PubMed ID: 11827799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Simple Luminescent Adenylate-Cyclase Functional Assay for Evaluation of Bacillus anthracis Edema Factor Activity.
    Israeli M; Rotem S; Elia U; Bar-Haim E; Cohen O; Chitlaru T
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27548219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratio of lethal and edema factors in rabbit systemic anthrax.
    Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
    Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides.
    Göttle M; Dove S; Steindel P; Shen Y; Tang WJ; Geduhn J; König B; Seifert R
    Mol Pharmacol; 2007 Sep; 72(3):526-35. PubMed ID: 17553924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic differences between in vitro assays for hydrazone-based small molecule inhibitors of anthrax lethal factor.
    Hanna ML; Tarasow TM; Perkins J
    Bioorg Chem; 2007 Feb; 35(1):50-8. PubMed ID: 16949126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A fluorimetric assay for real-time monitoring of adenylyl cyclase activity based on terbium norfloxacin.
    Spangler CM; Spangler C; Göttle M; Shen Y; Tang WJ; Seifert R; Schäferling M
    Anal Biochem; 2008 Oct; 381(1):86-93. PubMed ID: 18601890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
    Jiao GS; Simo O; Nagata M; O'Malley S; Hemscheidt T; Cregar L; Millis SZ; Goldman ME; Tang C
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5183-9. PubMed ID: 16870442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.
    Kuo SR; Willingham MC; Bour SH; Andreas EA; Park SK; Jackson C; Duesbery NS; Leppla SH; Tang WJ; Frankel AE
    Microb Pathog; 2008 Jun; 44(6):467-72. PubMed ID: 18222626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.
    Jiao GS; Cregar L; Goldman ME; Millis SZ; Tang C
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1527-31. PubMed ID: 16386899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.
    Schein CH; Chen D; Ma L; Kanalas JJ; Gao J; Jimenez ME; Sower LE; Walter MA; Gilbertson SR; Peterson JW
    Toxins (Basel); 2012 Nov; 4(11):1288-300. PubMed ID: 23202316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of a hydrolytically stable, fluorescent-labeled ATP analog as a tool for probing adenylyl cyclases.
    Emmrich T; El-Tayeb A; Taha H; Seifert R; Müller CE; Link A
    Bioorg Med Chem Lett; 2010 Jan; 20(1):232-5. PubMed ID: 19914832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo asymmetric synthesis of the anthrax tetrasaccharide by a palladium-catalyzed glycosylation reaction.
    Guo H; O'Doherty GA
    Angew Chem Int Ed Engl; 2007; 46(27):5206-8. PubMed ID: 17534991
    [No Abstract]   [Full Text] [Related]  

  • 35. Crystallization and preliminary X-ray study of the edema factor exotoxin adenylyl cyclase domain from Bacillus anthracis in the presence of its activator, calmodulin.
    Drum CL; Shen Y; Rice PA; Bohm A; Tang WJ
    Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1881-4. PubMed ID: 11717504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cAMP imaging of cells treated with pertussis toxin, cholera toxin, and anthrax edema toxin.
    Dal Molin F; Zornetta I; Puhar A; Tonello F; Zaccolo M; Montecucco C
    Biochem Biophys Res Commun; 2008 Nov; 376(2):429-33. PubMed ID: 18793614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor.
    Lewis JA; Mongan J; McCammon JA; Cohen SM
    ChemMedChem; 2006 Jul; 1(7):694-7. PubMed ID: 16902919
    [No Abstract]   [Full Text] [Related]  

  • 38. Anthrax edema factor toxicity is strongly mediated by the N-end rule.
    Leysath CE; Phillips DD; Crown D; Fattah RJ; Moayeri M; Leppla SH
    PLoS One; 2013; 8(8):e74474. PubMed ID: 24015319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combating the threat of anthrax: a quantitative structure-activity relationship approach.
    Verma RP; Hansch C
    Mol Pharm; 2008; 5(5):745-59. PubMed ID: 18611038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.